DCAF12L1
gene geneOn this page
Also known as KIAA1892L
Summary
DCAF12L1 (DDB1 and CUL4 associated factor 12 like 1, HGNC:29395) is a protein-coding gene on chromosome Xq25, encoding DDB1- and CUL4-associated factor 12-like protein 1 (Q5VU92).
This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation.
Source: NCBI Gene 139170 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 61 total — 1 likely-pathogenic
- MANE Select transcript:
NM_178470
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29395 |
| Approved symbol | DCAF12L1 |
| Name | DDB1 and CUL4 associated factor 12 like 1 |
| Location | Xq25 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1892L |
| Ensembl gene | ENSG00000198889 |
| Ensembl biotype | protein_coding |
| Entrez | 139170 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000371126
RefSeq mRNA: 1 — MANE Select: NM_178470
NM_178470
CCDS: CCDS14610
Canonical transcript exons
ENST00000371126 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001436827 | 126549383 | 126551107 |
| ENSE00001454400 | 126551195 | 126552814 |
Expression profiles
Bgee: expression breadth broad, 61 present calls, max score 84.73.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2797 / max 47.3639, expressed in 99 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200425 | 0.2797 | 99 |
Top tissues by expression
233 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.73 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.86 | gold quality |
| caput epididymis | UBERON:0004358 | 79.29 | gold quality |
| corpus epididymis | UBERON:0004359 | 78.09 | gold quality |
| cauda epididymis | UBERON:0004360 | 69.25 | gold quality |
| testis | UBERON:0000473 | 68.58 | gold quality |
| right testis | UBERON:0004534 | 68.23 | gold quality |
| left testis | UBERON:0004533 | 66.44 | gold quality |
| oviduct epithelium | UBERON:0004804 | 65.47 | gold quality |
| fallopian tube | UBERON:0003889 | 63.33 | gold quality |
| gall bladder | UBERON:0002110 | 62.61 | gold quality |
| seminal vesicle | UBERON:0000998 | 61.86 | gold quality |
| left uterine tube | UBERON:0001303 | 59.45 | gold quality |
| adult organism | UBERON:0007023 | 59.01 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 58.51 | silver quality |
| endometrium | UBERON:0001295 | 57.80 | gold quality |
| cartilage tissue | UBERON:0002418 | 57.22 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| pancreatic ductal cell | CL:0002079 | 54.16 | silver quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| right uterine tube | UBERON:0001302 | 53.49 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 53.37 | gold quality |
| body of stomach | UBERON:0001161 | 53.04 | gold quality |
| ovary | UBERON:0000992 | 52.81 | gold quality |
| fundus of stomach | UBERON:0001160 | 52.67 | gold quality |
| tibialis anterior | UBERON:0001385 | 52.33 | silver quality |
| metanephros | UBERON:0000081 | 52.31 | gold quality |
| ventricular zone | UBERON:0003053 | 52.21 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.80 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
83 targeting DCAF12L1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
Literature-anchored findings (GeneRIF, showing 1)
- Functionally characterizes other DDB1- and CUL4-associated factors, including the DCAF12 factor which most closely resembles the product of this gene. (PMID:16949367)
Cross-species orthologs
0 orthologs
Paralogs (2): DCAF12L2 (ENSG00000198354), DCAF12 (ENSG00000198876)
Protein
Protein identifiers
DDB1- and CUL4-associated factor 12-like protein 1 — Q5VU92 (reviewed: Q5VU92)
Alternative names: WD repeat-containing protein 40B
All UniProt accessions (1): Q5VU92
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the WD repeat DCAF12 family.
RefSeq proteins (1): NP_848565* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR051191 | DCAF12 | Family |
| IPR056151 | Beta-prop_DCAF12 | Domain |
Pfam: PF23760
UniProt features (9 total): repeat 6, chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VU92-F1 | 78.40 | 0.50 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 58 (showing top):
ACATTCC_MIR1_MIR206, TGCCTTA_MIR124A, GOCC_TRANSFERASE_COMPLEX, GOCC_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX, GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX, ZHENG_GLIOBLASTOMA_PLASTICITY_DN, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP, GOCC_UBIQUITIN_LIGASE_COMPLEX, ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP, MEISSNER_NPC_HCP_WITH_H3K4ME2, LU_EZH2_TARGETS_DN, chrXq25, KATSANOU_ELAVL1_TARGETS_UP, ZNF618_TARGET_GENES, MIR548AJ_3P_MIR548X_3P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): Cul4-RING E3 ubiquitin ligase complex (GO:0080008)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cullin-RING ubiquitin ligase complex | 1 |
Protein interactions and networks
STRING
444 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DCAF12L1 | DDB1 | Q16531 | 653 |
| DCAF12L1 | SH2D2A | Q9NP31 | 573 |
| DCAF12L1 | DCAF8L1 | A6NGE4 | 501 |
| DCAF12L1 | DCAF8L2 | P0C7V8 | 474 |
| DCAF12L1 | ANKRD20A1 | Q5TYW2 | 444 |
| DCAF12L1 | DCAF11 | Q8TEB1 | 429 |
| DCAF12L1 | PRR32 | B1ATL7 | 400 |
| DCAF12L1 | PRXL2C | Q7RTV5 | 400 |
| DCAF12L1 | PDCL2 | Q8N4E4 | 399 |
| DCAF12L1 | TMEM95 | Q3KNT9 | 391 |
| DCAF12L1 | FARP1 | Q9Y4F1 | 381 |
| DCAF12L1 | LRRC57 | Q8N9N7 | 370 |
| DCAF12L1 | NDUFA1 | O15239 | 368 |
| DCAF12L1 | CATSPERT | Q53TS8 | 357 |
| DCAF12L1 | GMPR | P36959 | 329 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCT2 | TXNDC9 | psi-mi:“MI:0914”(association) | 0.730 |
| PFDN2 | POLR3A | psi-mi:“MI:0914”(association) | 0.670 |
| DCAF12L2 | CETN3 | psi-mi:“MI:0914”(association) | 0.640 |
| BCL7A | ARID1A | psi-mi:“MI:0914”(association) | 0.640 |
| CCT3 | TXNDC9 | psi-mi:“MI:0914”(association) | 0.640 |
| CCT7 | TXNDC9 | psi-mi:“MI:0914”(association) | 0.640 |
| STAMBPL1 | PIK3C2A | psi-mi:“MI:0914”(association) | 0.640 |
| DCAF12L1 | SH2D2A | psi-mi:“MI:0915”(physical association) | 0.570 |
| SH2D2A | DCAF12L1 | psi-mi:“MI:0915”(physical association) | 0.570 |
| DRG1 | LRRC41 | psi-mi:“MI:0914”(association) | 0.530 |
| GPS1 | PXDNL | psi-mi:“MI:0914”(association) | 0.530 |
| KCTD17 | CBX4 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNRD2 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| CNGA3 | MAGEA6 | psi-mi:“MI:0914”(association) | 0.350 |
| COPS2 | RHOBTB1 | psi-mi:“MI:0914”(association) | 0.350 |
| CUL4B | CAND2 | psi-mi:“MI:0914”(association) | 0.350 |
| TNFRSF6B | FBXO21 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (6): DCAF12L1 (Two-hybrid), SH2D2A (Affinity Capture-Luminescence), DCAF12L1 (Affinity Capture-MS), DCAF12L1 (Affinity Capture-MS), DCAF12L1 (Affinity Capture-MS), DCAF12L1 (Proximity Label-MS)
ESM2 similar proteins: A1L112, A4IHS2, A8NZM5, B2ZZS9, O00423, O80775, O95834, P93107, P97452, Q05BC3, Q0DYP5, Q13216, Q13610, Q13685, Q15269, Q1JQD2, Q2HJ56, Q32KQ2, Q32P44, Q3SZK1, Q4V8C3, Q562C2, Q58DT8, Q5BIM8, Q5F3K4, Q5R9T6, Q5RCG7, Q5RFQ3, Q5VU92, Q5XI13, Q5ZK69, Q6DRF9, Q6P6T4, Q6PFM9, Q7TNG5, Q7YR70, Q810D6, Q8BH57, Q8BHB4, Q8BU03
Diamond homologs: Q08BB3, Q3MHH0, Q4R3J7, Q5F3R7, Q5T6F0, Q5VU92, Q5VW00, Q63ZP7, Q6AX81, Q6P809, Q8BGW4, Q8BGZ3, Q8CBW4, Q9VGE3, Q9AV81
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 29 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| RHOBTB1 GTPase cycle | 5 | 125.2× | 3e-08 |
| Neddylation | 5 | 12.5× | 4e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| protein stabilization | 5 | 11.9× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 36 |
| Likely benign | 10 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2690984 | NM_178470.5(DCAF12L1):c.406_407del (p.Leu136fs) | Likely pathogenic |
SpliceAI
142 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:126551220:G:C | donor_gain | 0.8700 |
| X:126551189:GTGTA:G | donor_loss | 0.8400 |
| X:126551190:TGTAC:T | donor_loss | 0.8400 |
| X:126551191:GTA:G | donor_loss | 0.8400 |
| X:126551192:TAC:T | donor_loss | 0.8400 |
| X:126551193:A:C | donor_loss | 0.8400 |
| X:126551194:C:G | donor_loss | 0.8400 |
| X:126551195:C:G | donor_loss | 0.8200 |
| X:126551214:T:TA | donor_gain | 0.7500 |
| X:126551106:AC:A | acceptor_loss | 0.6500 |
| X:126551107:CC:C | acceptor_loss | 0.6500 |
| X:126551109:T:G | acceptor_loss | 0.6500 |
| X:126551110:GGAAA:G | acceptor_loss | 0.6400 |
| X:126551111:GAAAA:G | acceptor_loss | 0.6400 |
| X:126551116:C:CT | acceptor_loss | 0.6400 |
| X:126551117:A:T | acceptor_loss | 0.6400 |
| X:126551112:AAAA:A | acceptor_loss | 0.6200 |
| X:126551219:AGCT:A | donor_gain | 0.6100 |
| X:126551335:T:TA | donor_gain | 0.6100 |
| X:126550822:ACT:A | acceptor_gain | 0.5800 |
| X:126551353:T:C | donor_gain | 0.5700 |
| X:126551132:T:TC | acceptor_loss | 0.5600 |
| X:126551408:T:TA | donor_gain | 0.5600 |
| X:126551108:C:CC | acceptor_gain | 0.5500 |
| X:126551113:AAACA:A | acceptor_loss | 0.5500 |
| X:126551114:AACAA:A | acceptor_loss | 0.5500 |
| X:126551115:ACAAA:A | acceptor_loss | 0.5500 |
| X:126551118:AAAGA:A | acceptor_loss | 0.5500 |
| X:126551131:GTTAA:G | acceptor_loss | 0.5500 |
| X:126550821:AACT:A | acceptor_gain | 0.5400 |
AlphaMissense
2995 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:126552296:A:G | W105R | 0.999 |
| X:126552296:A:T | W105R | 0.999 |
| X:126551979:G:C | S210R | 0.998 |
| X:126551979:G:T | S210R | 0.998 |
| X:126551981:T:G | S210R | 0.998 |
| X:126552294:C:A | W105C | 0.998 |
| X:126552294:C:G | W105C | 0.998 |
| X:126552080:A:C | Y177D | 0.996 |
| X:126551225:A:G | W462R | 0.995 |
| X:126551225:A:T | W462R | 0.995 |
| X:126551951:A:G | W220R | 0.995 |
| X:126551951:A:T | W220R | 0.995 |
| X:126552005:A:G | W202R | 0.995 |
| X:126552005:A:T | W202R | 0.995 |
| X:126552115:G:T | A165D | 0.995 |
| X:126551644:G:T | A322D | 0.994 |
| X:126552295:C:G | W105S | 0.994 |
| X:126552306:G:C | F101L | 0.994 |
| X:126552306:G:T | F101L | 0.994 |
| X:126552308:A:G | F101L | 0.994 |
| X:126551278:A:G | F444S | 0.993 |
| X:126551546:A:G | S355P | 0.993 |
| X:126551269:C:T | G447E | 0.992 |
| X:126552265:G:A | T115I | 0.992 |
| X:126552268:C:T | G114D | 0.992 |
| X:126551270:C:A | G447W | 0.991 |
| X:126552135:A:C | N158K | 0.991 |
| X:126552135:A:T | N158K | 0.991 |
| X:126551242:C:T | G456E | 0.990 |
| X:126551949:C:A | W220C | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000127603 (X:126554263 C>T), RS1002390113 (X:126550251 C>A,T), RS1003529531 (X:126551264 G>C), RS1004393150 (X:126554138 T>C), RS1004432170 (X:126552422 A>C), RS1004766582 (X:126553715 T>G), RS1004787363 (X:126551175 T>C,G), RS1005245083 (X:126550490 C>T), RS1006011729 (X:126548905 C>A,G), RS1006505780 (X:126552954 G>A,C,T), RS1007421954 (X:126551018 C>G), RS1008012847 (X:126552845 G>A,C,T), RS1008289158 (X:126553199 C>G), RS1008691300 (X:126549784 A>G), RS1009430124 (X:126554733 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (1): Male infertility with azoospermia or oligozoospermia due to single gene mutation (Orphanet:399805)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007594_3 | Handedness (Right-handed vs. non-right-handed) | 1.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009902 | handedness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression, increases methylation | 6 |
| Phenylmercuric Acetate | decreases expression, affects cotreatment | 2 |
| aristolochic acid I | decreases expression | 1 |
| trichostatin A | increases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression, increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression, increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Phthalic Acids | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| 8-Bromo Cyclic Adenosine Monophosphate | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.